Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 6 October 2006. doi:10.1136/gut.2006.102269
Gut 2007;56:475-479
Copyright © 2007 BMJ Publishing Group Ltd & British Society of Gastroenterology.

HELICOBACTER PYLORI

Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study

Rocco Maurizio Zagari1, Gabriele Bianchi-Porro2, Roberto Fiocca3, Giovanni Gasbarrini4, Enrico Roda1, Franco Bazzoli1

1 Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
2 Gastroenterology Unit, L Sacco Hospital, Milan, Italy
3 Division of Anatomic Pathology, University of Genoa, Genoa, Italy
4 Department of Internal Medicine, Policlinico Gemelli, Rome, Italy

Correspondence to:
Professor Franco Bazzoli
Dipartimento di Medicina Interna e Gastroenterologia, Università di Bologna, Policlinico S Orsola, Via Massarenti 9, 40138 Bologna, Italy;franco.bazzoli{at}Unibo.it

Background: Triple therapy is recommended for Helicobacter pylori eradication, yet consensus on the duration of treatment is lacking.

Aim: To compare the efficacy and safety of 1- and 2-week regimens of omeprazole, amoxicillin and clarithromycin in a large, multicentre, double-blind and randomised study.

Methods: A total of 909 H pylori-positive patients with duodenal ulcer, enrolled in 81 endoscopy units in Italy, were randomised to receive omeprazole, amoxicillin and clarithromycin for either 1 week (OAC1W) or 2 weeks (OAC2W) or omeprazole and amoxicillin for 2 weeks. H pylori eradication was assessed by histological examination and carbon-13 urea breath test 4 weeks after treatment.

Results: Both the intention-to-treat (ITT; n = 907) and per protocol (PP; n = 661) analyses showed no significant differences between the eradication rates of OAC1W (ITT 79.7%; PP 83.6%) and OAC2W (ITT 81.7%; PP 84.9%; ITT p = 0.53; PP p = 0.71). Both triple omeprazole, amoxicillin and clarithromycin regimens gave significantly higher eradication rates compared with omeprazole and amoxicillin treatment (ITT 44.6%; PP 42.8%; p<0.001). Poor compliance was reported in 18.6%, 17.3% and 15.1% (p = 0.51) of patients for OAC2W, OAC1W and omeprazole and amoxicillin, respectively. Adverse events occurred in 9.9% and 9.6% (p = 0.88) of patients for OAC2W and OAC1W, respectively, and in 5.9% for omeprazole and amoxicillin (p = 0.11).

Conclusions: 1-week and 2-week triple treatments for H pylori eradication are similar in terms of efficacy, safety and patient compliance.

Abbreviations: 13C-UBT, carbon-13 urea breath test; ITT, intention-to-treat; OAC1W, omeprazole 20 mg twice daily and amoxicillin 1 g twice daily and clarithromycin 500 mg twice daily for 1 week, followed by omeprazole 20 mg twice daily and placebo for 1 week; OAC2W, omeprazole 20 mg twice daily and amoxicillin 1 g twice daily and clarithromycin 500 g twice daily for 2 weeks; PPI, proton pump inhibitor


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

One- or two-week triple therapy for Helicobacter pylori: questions of efficacy and inclusion of a dual therapy treatment arm Authors’ response
David Y Graham, Yoshio Yamaoka, Rocco Maurizio Zagari, and Franco Bazzoli
Gut 2007 56: 1021-1023. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

  • O'Connor, J. P. A., Taneike, I., O'Morain, C. (2009). Review: Improving compliance with Helicobacter pylori eradication therapy: when and how?. Therapeutic Advances in Gastroenterology 2: 273-279 [Abstract]  
  • Fuccio, L, Laterza, L, Zagari, R M, Cennamo, V, Grilli, D, Bazzoli, F. (2008). Treatment of Helicobacter pylori infection. BMJ 337: a1454-a1454 [Full Text]  
  • Calvet, X., Villoria, A., Vergara, M. (2008). Could Increasing the Duration of Triple Therapy Be a Clinically Useful Strategy?. ANN INTERN MED 148: 624-624 [Full Text]  
  • Fuccio, L., Minardi, M. E., Zagari, R. M., Grilli, D., Magrini, N., Bazzoli, F. (2007). Meta-analysis: Duration of First-Line Proton-Pump Inhibitor-Based Triple Therapy for Helicobacter pylori Eradication. ANN INTERN MED 147: 553-562 [Abstract] [Full Text]  
  • Zullo, A., De Francesco, V., Hassan, C., Morini, S., Vaira, D. (2007). The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut 56: 1353-1357 [Abstract] [Full Text]  
  • (2007). One week of triple therapy usually eradicates H pylori. BMJ 334: 1082-1082 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs